MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

Meeting: 2016 International Congress

Abstract Number: 1876

Keywords: Motor control, Parkinsonism, Rehabilitation

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: This study aims to carry out validity and reliability of the Test dEvaluation des Membres Superieurs Des Personnes Agees (TEMPA) in patients with PD.

Background: There is no a specific tool to assess functional aspects of the upper limb (UL) in patients with PD. TEMPA is a tool used in other neurological diseases to assess Activity domain of UL. TEMPA contains unilateral and bilateral tasks that are representative of daily living activities including both quantitative and qualitative parameters.

Methods: The following psychometric properties of the TEMPA were evaluated in 52 subjects: inter-rater and test-retest reliability; concurrent validity assessed by the correlation of the TEMPA with sections (II, III) of the UPDRS; convergent validity, between correlation of TEMPA and Nine HolePeg Test (NHPT); discriminant validity, verified by comparing the TEMPA and Hoehn and Yahr scale. For the reliabilities evaluation was used the intraclass correlation coefficient (ICC) with confidence intervals (CI) of 95%, considering: weak agreement (ICC<0.40); moderate agreement (CCI≤0.75); and excellent agreement (ICC>0.75). The weighted kappa (Wk) was used to assess inter-rater agreement of TEMPA, for individual items and for the total score. The agreement was considered excellent for Wk values between 0.81-1.00; substantial, 0.61 to 0.80; moderate, 0.41 to 0.60; fair, 0.21 to 0.40; poor, 0-0.20, and with no agreement when equal to zero. Internal consistency was established using the Cronbach’s alpha, adopting a value from 0.70 to 0.90 for achieve a good agreement between the scale items. To analyze the discriminant validity, oneway ANOVA was used. Convergent and concurrent validity were determined by nonparametric Spearman correlation.

Results: Excellent reliability and inter-rater agreement (intraclass correlation coefficient – ICC=0.99 and weighted kappa – k=0.92)

The inter-rater reliability for the TEMPA total score, execution speed, functional and task analysis total scores
N=52 Rater 1 Median (mini –maxi) Rater 1 Means ± SD Rater 2 Median (mini – maxi) Rater 2 Means ± SD ICC (CI 95%) Wk (CI 95%)
Total Score 10.5 (1 – 58) 14.6 (13.3) 10 (1 – 57) 15 (13.7) 0.99 (0.98 – 0.99) 0.92 (0.89 – 0.94)
Speed of execution 236.4 (141 -531) 252.9 (87.6) 231.1 (138 – 527) 245.5 (81.9) 0.98 (0.97- 0.99) 0.91 (0.87 – 0.95)
Functional Rating 2 (0 – 14) 3.34 (3.24) 2 (0 – 14) 3.0 (3.1) 0.97 (0.96 – 0.98) 0.88 (0.81 – 0.95)
Task analysis 8 (1 – 44) 11.2 (10.2) 8.5 (0 – 43) 12 (10.8) 0.98 (0.97 – 0.99) 0.89 (0.85 – 0.93)
ICC= intraclass correlation coefficient: CI= confidence intervals Wk weighted kappa;SD= standard deviation” and test-retest reliability (ICC=0.97)

The test-retest reliability for the TEMPA total score, execution speed, functional rating and task analysis total scores
N=25, Florianopolis Rater 1 Median (mini – max.) Rater 1 Means ± SD ICC – (CI 95 %)
Total Score 14 (1- 57) 15.7 (13.8) 0.97 (0.95 – 0.99)
Speed of execution 247.5 (138.6 – 548.1) 259 (93.8) 0.89 (0.7 – 0.97)
Functional rating 2 (0 – 13) 3.5 (2.6) 0.97 (0.94 – 0.98)
Task analysis 12 (1 – 57) 12.3 (10.4) 0.95 (0.94 – 0.98)
N=27, Rio de Janeiro Rater 2 Median (mini – maxi.) Rater 2 Means ± SD ICC- (CI 95 %)
Total Score 8 (1- 48) 13.1 (12.9) 0.99 (0.99 – 1)
Speed of execution 191.1 (109.7 – 370.6) 200.9 (59.4) 0.69 (0.42 – 0.85)
Functional rating 2 (0 – 10) 2.7 (2.8) 0.98 (0.95 – 0.99)
Task analysis 6 (1 – 38) 10.4 (10.4) 0.99 (0.99 – 1)
ICC= intraclass correlation coefficient: CI= confidence intervals Wk weighted kappa;SD= standard deviation” for TEMPA. It was found a negative moderate correlation between the TEMPA and section II of the UPDRS (ρ=-0.58; p=0.000), moderate correlations between the test and NHPT values of the right and left UL (ρ=0.56 and ρ=0.41; p=0.000) (ρ=0.52 and ρ=0.51; p=0.000 and p=0.002), respectively. There was no significant relationship between the group that presented freezing episodes (p=0.057).

Conclusions: TEMPA showed adequate psychometric properties in patients with PD.

To cite this abstract in AMA style:

C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky. Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/validity-and-reliability-of-the-test-d-evaluation-des-membres-superieurs-de-personnes-agees-tempa-to-assess-upper-limb-in-parkinsons-disease/. Accessed July 9, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validity-and-reliability-of-the-test-d-evaluation-des-membres-superieurs-de-personnes-agees-tempa-to-assess-upper-limb-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley